Issued Patents All Time
Showing 1–25 of 57 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11584717 | MIF modulators | William L. Jorgensen | 2023-02-21 |
| 10842859 | Uses of parasite macrophage migration inhibitory factors | Andrew Geall | 2020-11-24 |
| 10765739 | Use of MIF and MIF pathway agonists | Lawrence H. Young | 2020-09-08 |
| 10202343 | MIF modulators | William L. Jorgensen | 2019-02-12 |
| 9643922 | MIF modulators | William L. Jorgensen | 2017-05-09 |
| 9540322 | MIF modulators | William L. Jorgensen | 2017-01-10 |
| 9308255 | Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury | Lawrence H. Young | 2016-04-12 |
| 9221903 | Method of inhibiting binding or activity of MIF by administering a MIF antagonist | Lin Leng, Christine N. Metz | 2015-12-29 |
| 9139877 | Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease | John Baugh, Smita Chitnis, Seamus C. Donnelly, Peter K. Gregersen, Joanita Monteiro | 2015-09-22 |
| 8779099 | MIF antagonists | Lin Leng, Christine N. Metz | 2014-07-15 |
| 8617822 | Method of inhibiting binding or activity of MIF by administering a MIF antagonist | Lin Leng, Christine N. Metz | 2013-12-31 |
| 7745121 | Polymorphism in the macrophage migration inhibitory factor (MIF) gene as marker for prostate cancer | Katherine Siegler, Kenneth Iczkowski, Pedro Vera | 2010-06-29 |
| 7741057 | Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor | Lin Leng, Christine N. Metz | 2010-06-22 |
| 7517523 | Anti-MIF antibodies | Robert A. Mitchell, Jurgen Bernhagen, Thierry Calandra, Anthony Cerami | 2009-04-14 |
| 7205107 | Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease | John Baugh, Smita Chitnis, Seamus C. Donnelly, Peter K. Gregersen, Joanita Monteiro | 2007-04-17 |
| 6998238 | Method for determining MIF content | Robert A. Mitchell, Jurgen Bernhagen, Thierry Calandra, Anthony Cerami | 2006-02-14 |
| 6774227 | Therapeutic uses of factors which inhibit or neutralize MIF activity | Jason Chesney | 2004-08-10 |
| 6759036 | Fibrocyte-base vaccine formulations | Glenn C. Rice | 2004-07-06 |
| 6645493 | Composition containing anti-MIF antibody | Robert A. Mitchell, Jurgen Bernhagen, Thierry Calandra, Anthony Cerami | 2003-11-11 |
| 6599938 | Compounds having MIF antagonist activity | Yousef Al-Abed | 2003-07-29 |
| 6596851 | Inducible phosphofructokinase and the Warburg effect | Jason Chesney, Robert A. Mitchell | 2003-07-22 |
| 6492428 | Compounds having MIF antagonist activity | Yousef Al-Abed, Robert A. Mitchell, Peter D. Senter | 2002-12-10 |
| 6420188 | Screening assay for the identification of inhibitors for macrophage migration inhibitory factor | Peter C. Ulrich, Xini Xhang, Anthony Cerami | 2002-07-16 |
| 6413939 | Inducible phosphofructokinase and the Warburg effect | Jason Chesney, Robert A. Mitchell | 2002-07-02 |
| 6410598 | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis | Michael P. Vitek, Anthony Cerami, Peter C. Ulrich, Helen Vlassara, Xini Zhang | 2002-06-25 |